Literature DB >> 21671143

Vaccinomics: current findings, challenges and novel approaches for vaccine development.

Inna G Ovsyannikova1, Gregory A Poland.   

Abstract

Recent years have witnessed a growing interest in a field of vaccinology that we have named vaccinomics. The overall idea behind vaccinomics is to identify genetic and other mechanisms and pathways that determine immune responses, and thereby provide new candidate vaccine approaches. Considerable data show that host genetic polymorphisms act as important determinants of innate and adaptive immunity to vaccines. This review highlights examples of the role of immunogenetics and immunogenomics in understanding immune responses to vaccination, which are highly variable across the population. The influence of HLA genes, non-HLA, and innate genes in inter-individual variations in immune responses to viral vaccines are examined using population-based gene/SNP association studies. The ability to understand relationships between immune response gene variants and vaccine-specific immunity may assist in designing new vaccines. At the same time, application of state-of-the-art next-generation sequencing technology (and bioinformatics) is desired to provide new genetic information and its relationship to the immune response.

Mesh:

Substances:

Year:  2011        PMID: 21671143      PMCID: PMC3160164          DOI: 10.1208/s12248-011-9281-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  61 in total

Review 1.  Cytokine gene polymorphisms in multifactorial diseases: gateways to novel targets for immunotherapy?

Authors:  Koen Vandenbroeck; An Goris
Journal:  Trends Pharmacol Sci       Date:  2003-06       Impact factor: 14.819

Review 2.  The extent and analysis of cytokine and cytokine receptor gene polymorphism.

Authors:  Leigh J Keen
Journal:  Transpl Immunol       Date:  2002-08       Impact factor: 1.708

Review 3.  Genome-wide association studies for common diseases and complex traits.

Authors:  Joel N Hirschhorn; Mark J Daly
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

Review 4.  Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.

Authors:  G A Poland; I G Ovsyannikova; R M Jacobson; D I Smith
Journal:  Clin Pharmacol Ther       Date:  2007-10-31       Impact factor: 6.875

5.  Therapeutics and toxicology.

Authors:  S P Spielberg
Journal:  Curr Opin Pediatr       Date:  1998-04       Impact factor: 2.856

6.  Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins.

Authors:  Thomas Höhler; Esther Reuss; Nina Evers; Evi Dietrich; Christian Rittner; Christine M Freitag; Jens Vollmar; Peter M Schneider; Rolf Fimmers
Journal:  Lancet       Date:  2002-09-28       Impact factor: 79.321

Review 7.  Immunogenetics of seasonal influenza vaccine response.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

8.  Humoral immune responses to a protective peptide-conjugate against measles after different prime-boost regimens.

Authors:  Mike M Pütz; Wim Ammerlaan; François Schneider; Günther Jung; Claude P Muller
Journal:  Vaccine       Date:  2004-10-22       Impact factor: 3.641

9.  Associations between human leukocyte antigen (HLA) alleles and very high levels of measles antibody following vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Vaccine       Date:  2004-05-07       Impact factor: 3.641

10.  Role of common human TRIM5alpha variants in HIV-1 disease progression.

Authors:  Valérie Goldschmidt; Gabriela Bleiber; Margaret May; Raquel Martinez; Millàn Ortiz; Amalio Telenti
Journal:  Retrovirology       Date:  2006-08-22       Impact factor: 4.602

View more
  23 in total

1.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 2.  Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Richard B Kennedy; Iana H Haralambieva; Robert M Jacobson
Journal:  OMICS       Date:  2011-07-06

3.  Replication of associations between cytokine and cytokine receptor single nucleotide polymorphisms and measles-specific adaptive immunophenotypic extremes.

Authors:  Sarah J White; Iana H Haralambieva; Inna G Ovsyannikova; Robert A Vierkant; Megan M O'Byrne; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-04-12       Impact factor: 2.850

Review 4.  Moving beyond Titers.

Authors:  Benjamin D Brooks; Alexander Beland; Gabriel Aguero; Nicholas Taylor; Francina D Towne
Journal:  Vaccines (Basel)       Date:  2022-04-26

Review 5.  The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines.

Authors:  Abdulmohammad Pezeshki; Inna G Ovsyannikova; Brett A McKinney; Gregory A Poland; Richard B Kennedy
Journal:  Expert Rev Vaccines       Date:  2019-02-11       Impact factor: 5.217

Review 6.  Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approach.

Authors:  Nathaniel D Lambert; Inna G Ovsyannikova; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2012-08       Impact factor: 5.217

Review 7.  Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.

Authors:  Gregory A Poland; Richard B Kennedy; Brett A McKinney; Inna G Ovsyannikova; Nathaniel D Lambert; Robert M Jacobson; Ann L Oberg
Journal:  Semin Immunol       Date:  2013-06-05       Impact factor: 11.130

Review 8.  The future potential for cocaine vaccines.

Authors:  Frank M Orson; Rongfu Wang; Stephen Brimijoin; Berma M Kinsey; Rana Ak Singh; Muthu Ramakrishnan; Helen Y Wang; Thomas R Kosten
Journal:  Expert Opin Biol Ther       Date:  2014-05-16       Impact factor: 4.388

9.  OptiType: precision HLA typing from next-generation sequencing data.

Authors:  András Szolek; Benjamin Schubert; Christopher Mohr; Marc Sturm; Magdalena Feldhahn; Oliver Kohlbacher
Journal:  Bioinformatics       Date:  2014-08-20       Impact factor: 6.937

10.  Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.

Authors:  Tobias R Kollmann
Journal:  Front Immunol       Date:  2013-04-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.